RESEARCHER PROFILE
Miguel L. Prieto
← Back to Universidad de Los Andes, Chile
M
Universidad de Los Andes, Chile
Miguel L. Prieto works in Bipolar Disorder and Treatment, Schizophrenia research and treatment, Genetic Associations and Epidemiology, Treatment of Major Depression, Personality Disorders and Psychopathology. Recorded institutional associations include Mayo Clinic, Universidad de Los Andes, Universidad de Los Andes, Chile.
65Publications
2,166Citations
21H-index
Inclusion identifies researchers whose recorded research contributions may inform their university’s understanding of its research community. It does not rank individual research quality or establish current employment.
Selected research works
Up to 100 highly cited works; DOI links open the original research. Counts reflect the collected record, not real-time citation totals.
Genome-wide Association Studies in Ancestrally Diverse Populations: Opportunities, Methods, Pitfalls, and Recommendations
2019 · 790 citationsIncreased cardiovascular mortality in people with schizophrenia: a 24-year national register study
2017 · 161 citationsCall to action regarding the vascular‐bipolar link: A report from the Vascular Task Force of the International Society for Bipolar Disorders
2020 · 112 citationsRisk of myocardial infarction and stroke in bipolar disorder: a systematic review and exploratory meta‐analysis
2014 · 99 citationsPrevalence and correlates of DSM-5 eating disorders in patients with bipolar disorder
2015 · 81 citationsDevelopment of a bipolar disorder biobank: differential phenotyping for subsequent biomarker analyses
2015 · 73 citationsClinical phenotype of bipolar disorder with comorbid binge eating disorder
2013 · 68 citationsPurinergic Signaling and Energy Homeostasis in Psychiatric Disorders
2015 · 58 citationsChange in consumption patterns for treatment-seeking patients with alcohol use disorder post-bariatric surgery
2014 · 53 citationsAssociation of schizophrenia polygenic risk score with manic and depressive psychosis in bipolar disorder
2018 · 53 citationsSex differences in the risk of rapid cycling and other indicators of adverse illness course in patients with bipolar I and II disorder
2015 · 46 citationsElevated baseline serum glutamate as a pharmacometabolomic biomarker for acamprosate treatment outcome in alcohol-dependent subjects
2015 · 44 citationsClinical features of bipolar spectrum with binge eating behaviour
2016 · 39 citationsLong-term risk of myocardial infarction and stroke in bipolar I disorder: A population-based Cohort Study
2016 · 38 citationsClinical Risk Factors and Serotonin Transporter Gene Variants Associated With Antidepressant-Induced Mania
2015 · 36 citationsActivation of neurotensin receptor type 1 attenuates locomotor activity
2014 · 36 citationsCurrent landscape, unmet needs, and future directions for treatment of bipolar depression
2014 · 36 citationsAccumulating evidence for a role of TCF 7L2 variants in bipolar disorder with elevated body mass index
2016 · 32 citationsInsulin resistance in bipolar disorder: A systematic review of illness course and clinical correlates
2023 · 32 citationsThe genetics of bipolar disorder with obesity and type 2 diabetes
2022 · 22 citationsDifferent patterns of manic/hypomanic symptoms in depression: A pilot modification of the hypomania checklist-32 to assess mixed depression
2014 · 21 citationsAntidepressants that increase mitochondrial energetics may elevate risk of treatment-emergent mania
2022 · 21 citationsA multinational study to pilot the modified Hypomania Checklist (mHCL) in the assessment of mixed depression
2013 · 20 citationsQuantification of diet quality utilizing the rapid eating assessment for participants-shortened version in bipolar disorder: Implications for prospective depression and cardiometabolic studies
2022 · 20 citationsCytochrome P450 2C19 Poor Metabolizer Phenotype in Treatment Resistant Depression: Treatment and Diagnostic Implications
2019 · 19 citations
